In fact, most of the studies have focused on demonstrating the PRR’s role in hypertension, cardiovascular and renal disease, and organ injury, as well as identifying the PRR as a therapeutic target to improve the RAS [13]. This evidence concerns the gene ATP6AP2 and kidney disorder.